On 2025-05-06, Arcus Biosciences, Inc. (RCUS) announced earnings per share of $-1.14 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.02.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-1.14 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-1.02 | $-1.14 |
| 2025-02-25 | 2024-12-31 | $-1.17 | $-1.03 |
| 2024-11-06 | 2024-09-30 | $-1.07 | $-1.00 |
| 2024-08-08 | 2024-06-30 | $-1.02 | $-1.02 |
| 2024-05-08 | 2024-03-31 | $-0.97 | $-0.05 |
| 2024-02-21 | 2023-12-31 | $-1.09 | $-1.08 |
| 2023-11-07 | 2023-09-30 | $-1.12 | $-0.94 |
| 2023-08-07 | 2023-06-30 | $-1.00 | $-1.04 |
| 2023-05-09 | 2023-03-31 | $-1.06 | $-1.09 |
| 2023-02-28 | 2022-12-31 | $-0.99 | $-0.93 |
| 2022-11-02 | 2022-09-30 | $-1.05 | $-0.90 |
| 2022-08-03 | 2022-06-30 | $-0.93 | $-0.93 |
| 2022-05-09 | 2022-03-31 | $0.83 | $-0.96 |
| 2022-02-23 | 2021-12-31 | $-1.13 | $3.71 |
| 2021-11-08 | 2021-09-30 | $-1.13 | $-1.11 |
| 2021-08-05 | 2021-06-30 | $-0.77 | $-1.09 |
| 2021-05-05 | 2021-03-31 | $-0.71 | $-1.08 |
| 2021-02-24 | 2020-12-31 | $-0.62 | $-0.82 |
| 2020-11-05 | 2020-09-30 | $0.35 | $0.03 |
| 2020-08-06 | 2020-06-30 | $-0.54 | $-0.93 |
| 2020-05-05 | 2020-03-31 | $-0.56 | $-0.63 |
| 2020-03-05 | 2019-12-31 | $-0.49 | $-0.38 |
| 2019-11-05 | 2019-09-30 | $-0.47 | $-0.51 |
| 2019-08-06 | 2019-06-30 | $-0.37 | $-0.64 |
| 2019-05-02 | 2019-03-31 | $-0.33 | $-0.41 |
| 2019-03-05 | 2018-12-31 | $-0.42 | $-0.28 |
| 2018-11-08 | 2018-09-30 | $-0.40 | $-0.25 |
| 2018-08-06 | 2018-06-30 | $-0.39 | $-0.32 |
| 2018-05-09 | 2018-03-31 | $-0.45 | $-1.37 |